The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor
Open accessAbstract
Background Activity-dependent release of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC) is essential for the rapid and sustained antidepressant actions of ketamine, and a recent study shows a similar requirement for vascular endothelial growth factor (VEGF). Since BDNF is reported to stimulate VEGF expression and/or release in neuroblastoma cells, the present study tested the hypothesis that the actions of BDNF are mediated by VEGF.Methods The role of VEGF in the antidepressant behavioral actions of BDNF was tested by intra-mPFC coinfusion of a VEGF neutralizing antibody and by neuron-specific deletion of VEGF. The influence of BDNF on the release of VEGF and the role of VEGF in the neurotrophic actions of BDNF were determined in rat primary cortical neurons. The role of BDNF in the behavioral and neurotrophic actions of VEGF was also determined.Results The results show that the rapid and sustained antidepressant-like actions of intra-mPFC BDNF are blocked by coinfusion of a VEGF neutralizing antibody, and that neuron-specific mPFC deletion of VEGF blocks the antidepressant-like actions of BDNF. Studies in primary cortical neurons demonstrate that BDNF stimulates the release of VEGF and that BDNF induction of dendrite complexity is blocked by a selective VEGF-fetal liver kinase 1 receptor antagonist. Surprisingly, the results also show reciprocal interactions, indicating that the behavioral and neurotrophic actions of VEGF are dependent on BDNF.Conclusions These findings indicate that the antidepressant-like and neurotrophic actions of BDNF require VEGF signaling, but they also demonstrate reciprocal interdependence for BDNF in the actions of VEGF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mTORC1 activation appears to be driven by BDNF signaling, and in turn, mTORC1 itself might enhance BDNF production, creating a positive feedback loop that sustains neuroplasticity [75,76].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [75]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a single infusion of recombinant BDNF into the mPFC produces rapid and sustained antidepressant effects similar to those observed with ketamine administration [75,76]”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Self-citation
Cited by
Sorted by citations
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335
Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321
Self-citationNeurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186
Self-citationNeurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 168
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Hanson, J. E., Yuan, H., Perszyk, R. E., Banke, T. G., Xing, H., Tsai, M., Menniti, F. S., & Traynelis, S. F. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01614-3 · Cited by 121
Li, G., Zhao, M., Cheng, X., Zhao, T., Feng, Z., Zhao, Y., Fan, M., & Zhu, L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00807-3 · Cited by 82
Kang, M. J. Y., Hawken, E., & Vazquez, G. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.860882 · Cited by 77
Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities
Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54
Dattilo, V., Amato, R., Perrotti, N., & Gennarelli, M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00826 · Cited by 49
Brain stimulation effects on serum BDNF, VEGF, and TNFα in treatment‐resistant psychiatric disorders
Valiulienė, G., Valiulis, V., Dapšys, K., Vitkevičienė, A., Gerulskis, G., Navakauskienė, R., & Germanavičius, A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15232 · Cited by 52
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
Deyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 46
Self-citationHan, H., Yao, J., Wu, J., Mao, S., Pan, H., Qv, L., Zhu, G., Ren, J., Yu, Y., Xuan, F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03044-7 · Cited by 46
Rejdak, K., Sienkiewicz‐Jarosz, H., Bieńkowski, P., & Álvarez, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21960 · Cited by 44
He, Y., Li, W., Wang, Y., Tian, Y., Chen, X., Wu, Z., Lan, T., Li, Y., Bai, M., Liu, J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.131 · Cited by 46
Deyama, S., Kondo, M., Shimada, S., & Kaneda, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01943-9 · Cited by 44
Self-citationAntidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41
Chaperone Sigma1R and Antidepressant Effect
Воронин, М. В., Vakhitova, Y. V., & Середенин, С. Б. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197088 · Cited by 41
Khalil, M. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312924 · Cited by 44
Lu, X., Liu, H., Cai, Z., Hu, Z., Ye, M., Gu, Y., Wang, Y., Wang, D., Lu, Q., Shen, Z., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.005 · Cited by 38
Hashimoto, K., Zhao, M., Zhu, T., Wang, X., & Yang, J. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.07.001 · Cited by 38
Li, W.-Y., Zhu, Q., Jin, L.-Y., Yang, Y., Xu, X.-Y., & Hu, X.-Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308665 · Cited by 38
Elia, A., Cannavò, A., Gambino, G., Cimini, M., Ferrara, N., Kishore, R., Paolocci, N., & Rengo, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.07.009 · Cited by 31
Müller, L., & Benedetto, S. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00341-z · Cited by 31
Pu, J., Liu, Y., Gui, S., Tian, L., Xu, S., Song, X., Zhong, X., Chen, Y., Chen, X., Yu, Y., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113319 · Cited by 30
Tang, Y., Su, H., Wang, H., Lu, F., Nie, K., Wang, Z., Huang, W., & Dong, H. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00414-z · Cited by 30
The Antidepressant-Like Effects of Shen Yuan in a Chronic Unpredictable Mild Stress Rat Model
Jiang, N., Wang, H., Huang, H. M., Lv, J., Zeng, G., Wang, Q., Bao, Y., Chen, Y., & Liu, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.622204 · Cited by 29
Astrocyte-derived lactate in stress disorders
Chamaa, F., Magistretti, P. J., & Fiumelli, H. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106417 · Cited by 31
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Borsellino, P., Krider, R. I., Chea, D., Grinnell, R., & Vida, T. A. (2023) · Pharmaceuticals · doi:10.3390/ph16050742 · Cited by 29
Ma, H., Li, J., Qiao, X., Zhang, Y., Hou, X.-J., Chen, H., Chen, H., Zhang, Y., & Li, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01201-8 · Cited by 28
Kranaster, L., Blennow, K., Zetterberg, H., & Sartorius, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.080 · Cited by 27
Medeiros, G. C., Greenstein, D., Kadriu, B., Yuan, P., Park, L. T., Gould, T. D., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.011 · Cited by 24
Joshi, R., & Salton, S. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.932497 · Cited by 25
Ren, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110910 · Cited by 23
Castillo, M. F. R., Cohen, A. J., Edberg, D., Hoppensteadt, D., Fareed, J., Martin, B., & Halaris, A. E. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112781 · Cited by 23
Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression
Zhou, X., Bao, W.-D., Liu, D., & Zhu, L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191101124017 · Cited by 22
Haleem, E. N. A. A., Ahmed, H. I., & El‐Naga, R. N. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1988797 · Cited by 21
The interplay of neurovasculature and adult hippocampal neurogenesis
Kim, T. A., Chen, L., & Ge, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136071 · Cited by 20
Deyama, S., Aoki, S., Sugie, R., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2023) · Neurotherapeutics · doi:10.1007/s13311-022-01337-1 · Cited by 18
Self-citationCurcumin attenuates brain aging by reducing apoptosis and oxidative stress
Cheriki, M., Habibian, M., & Moosavi, S. J. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-023-01326-z · Cited by 18
Deyama, S., & Kaneda, K. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112844 · Cited by 18
Self-citationResolvins as potential candidates for the treatment of major depressive disorder
Deyama, S., Minami, M., & Kaneda, K. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.002 · Cited by 18
Self-citationResolution of depression: Antidepressant actions of resolvins
Deyama, S., Kaneda, K., & Minami, M. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.10.006 · Cited by 18
Self-citationNeuron-specific deletion of VEGF or its receptor Flk-1 impairs recognition memory
Deyama, S., Li, X., & Duman, R. S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.11.002 · Cited by 17
Self-citationThe Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Fígaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., Baes, C. V. W., Coeli‐Lacchini, F. B., Tanus-Santos, J. E., Juruena, M. F., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122757 · Cited by 17
Involvement of muscarinic receptor mechanisms in antidepressant drug action.
Witkin, J., Smith, J., Golani, L., Brooks, E., & Martin, A. E. (2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.03.003 · Cited by 15
Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels
Robinson, B. L., Gu, Q., & Kanungo, J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00411 · Cited by 16
Zhang, L., Liu, X., Li, T., Xu, B., & Fu, B. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s334647 · Cited by 18
Vascular endothelial growth factor: a key factor in the onset and treatment of depression
Wang, J., Meng, F., Wang, L., & Li, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1645437 · Cited by 16
Николаевна, Н. И., Greco, V., Sciuto, S., Attanasio, F., & Rizzarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413504 · Cited by 15
Tsai, S., Kao, C.-F., Su, T., Li, C., Lin, W., Hong, C., Bai, Y., Tu, P., & Chen, M. (2023) · CNS Drugs · doi:10.1007/s40263-023-00989-7 · Cited by 15
Bränn, E., Skalkidou, A., Schwarz, J. M., Papadopoulos, F. C., Poromaa, I. S., & Fransson, E. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100468 · Cited by 14
The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice
Aoki, S., Deyama, S., Sugie, R., Ishimura, K., Fukuda, H., Shuto, S., Minami, M., & Kaneda, K. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113676 · Cited by 14
Self-citationSerum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13
Zhang, Y., Pan, Y., Zheng, W.-Y., Li, H.-Y., Zhu, M., yang, W.-J. O., Qian, Y., Turecki, G., Mechawar, N., & Zhu, X. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103005 · Cited by 13
The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
Markov, D. D., Dolotov, O. V., & Grivennikov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076664 · Cited by 14
Zheng, W., Gu, L.-M., Zhou, Y.-L., Wang, C.-Y., Lan, X.-F., Zhang, B., Shi, H.-S., Wang, D.-F., & Ning, Y.-P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.780975 · Cited by 12
Chitin conduits modified with DNA-peptide coating promote the peripheral nerve regeneration
Liu, S., Zhou, L., Li, C., Min, T., Lu, C., Han, S., Zhang, M., Wen, Y., Zhang, P., & Jiang, B. (2021) · Biofabrication · doi:10.1088/1758-5090/ac3bdc · Cited by 12
Can, A., Mitchell, J., Dutton, M., Bennett, M. R., Hermens, D. F., & Lagopoulos, J. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13572 · Cited by 11
Wang, Z., Hu, X., Wang, Z., Chen, J., Wang, L., Li, C., Deng, J., Yue, K., Wang, L., Kong, Y., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.019 · Cited by 10
Zheng, W., Zhou, Y., Wang, C., Lan, X., Zhang, B., Zhou, S., Yan, S., Yang, M., Nie, S., & Ning, Y. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211014320 · Cited by 10
Deyama, S., Sugie, R., Tabata, M., & Kaneda, K. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2254542 · Cited by 9
Self-citationLi, C., Zhang, J., Liu, H., Yuan, H., Cai, J., Fogaça, M. V., & Zhang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115137 · Cited by 8
Chen, M., Lin, W., Li, C., Wu, H.-J., Bai, Y., Tsai, S., Su, T., & Tu, P. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.022 · Cited by 8
Matsuzaka, Y., & Yashiro, R. (2025) · Biologics · doi:10.3390/biologics5010007 · Cited by 9
A rat study model of depression‐driven chronic prostatitis by modulating the PI3K /Akt/ mTOR network
Feng, J., Hou, D., Zhao, C., Bao, B., Huang, S., Deng, S., Meng, F., Zhao, Q., Wang, B., Li, H., et al. (2022) · Andrologia · doi:10.1111/and.14488 · Cited by 8
Faraji, J., & Metz, G. A. S. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.73 · Cited by 8
The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
Park, D., Lee, G., Lee, W.-G., Kim, B. S., Lee, Y., & Kim, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03100-2 · Cited by 11
Zheng, W., Gu, L.-M., Zhou, Y., Wang, C., Lan, X., Zhang, B., & Ning, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.855995 · Cited by 7
Maurer, J., Yanez, A., Bengtson, C. P., Bading, H., Draguhn, A., Mauceri, D., & Both, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.012 · Cited by 7
Zhang, Y., Li, X., Wang, X., Wang, X., Li, G., Xue, Q.-Y., Zhang, M., & Ao, H. (2023) · Pharmaceuticals · doi:10.3390/ph16111607 · Cited by 6
Self-citationThe impact of chronic pain on brain gene expression
Collier, L., Seah, C., Hicks, E. M., Holtzheimer, P. E., Krystal, J. H., Girgenti, M. J., Huckins, L. M., & Johnston, K. J. A. (2025) · Pain · doi:10.1097/j.pain.0000000000003707 · Cited by 6
Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19
Razi, O., Tartibian, B., Laher, I., Govindasamy, K., Zamani, N., Rocha‐Rodrigues, S., Suzuki, K., & Zouhal, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.783251 · Cited by 6
Deyama, S., Li, X., & Duman, R. S. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12393 · Cited by 5
Self-citationHan, X., Wu, Y., Zhong, Y., & Becker, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00736 · Cited by 5
Resolvins as novel targets for rapid-acting antidepressants
Deyama, S. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20044 · Cited by 5
Self-citationMarkiewicz, R., Markiewicz-Gospodarek, A., Dobrowolska, B. B., Bojar, I., & Łoza, B. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/163327 · Cited by 4
Quigley, B. L., Wellington, N. J., Levenstein, J. M., Dutton, M., Bouças, A. P., Forsyth, G., Gallay, C. C., Hajishafiee, M., Treacy, C., Lagopoulos, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91840-0 · Cited by 6
Liu, Y., Zou, L., Wang, P., Zhou, J., Yuan, C., & Wang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9794 · Cited by 4
Antidepressant-like effects of trophic factor receptor signaling
Sathyanesan, M., & Newton, S. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.958797 · Cited by 3
Ahtiainen, A., Genocchi, B., Subramaniyam, N. P., Tanskanen, J. M. A., Rantamäki, T., & Hyttinen, J. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16182 · Cited by 3
Chu, H., Sun, N., Tang, Q., Yu, X. L., Li, L., & Hong-sheng, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119960 · Cited by 3
Xu, Q., Liang, R., Gao, J., Fan, Y., Dong, J., Wang, L., Zheng, C., Yang, J., & Ming, D. (2024) · Life Sciences in Space Research · doi:10.1016/j.lssr.2024.04.001 · Cited by 3
Zhang, S., Chen, Q., Wu, L., Sun, K., Lan, X., Xie, X., & Yan, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5750647 · Cited by 3
RetractedLiu, C., Hu, W., Feng, X., & Qu, F. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.10.003 · Cited by 2
Galanin, I. V., Нарышкин, А. Г., Ляскина, И. Ю., & Александрович, С. Т. (2022) · Human Physiology · doi:10.1134/s0362119722020062 · Cited by 2
Reese, S. E., Conradt, E. D., Riquino, M. R., & Garland, E. L. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.688359 · Cited by 2
Deyama, S., Mishiro, K., Kunishima, M., & Kaneda, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178301 · Cited by 1
Self-citationНиколаевна, Н. И., & Rizzarelli, E. (2025) · Antioxidants · doi:10.3390/antiox14121512 · Cited by 1
Quigley, B. L., Orr, E., Kafka, S., Hajishafiee, M., Bouças, A. P., Wellington, N. J., Dutton, M., Jones, M., Randall, F., Lagopoulos, J., et al. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07043-6 · Cited by 1
Xue, L., Pan, Z., Liu, Y., Gan, Q., Liu, D., & Liu, D. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111856 · Cited by 1
Perineural invasion: A neuroimmune axis mediating immunotherapy resistance across malignancies
Guo, J., Hu, Z., Wu, L., Liu, L., Li, Z., Xiong, L., & Yu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116636 · Cited by 1
Chapter 14. Citalopram and Escitalopram
Shelton, R. C. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as14 · Cited by 1
Deyama, S. (2023) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.23-00111 · Cited by 1
Self-citationNeuron-Glia Signaling Regulates the Onset of the Antidepressant ResponsePreprint
Yao, V., Aly, A., Kalik, S., Gresack, J. E., Wang, W., Handler, A., Schaefer, A., Troyanskaya, O. G., Greengard, P., & Chottekalapanda, R. U. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453443 · Cited by 1
Habibian, M., & Moosavi, S. J. (2023) · Preprints.org · doi:10.20944/preprints202302.0290.v1
The neurobiology of treatment-resistant depression
Shelton, R. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00004-9
Lima‐Ojeda, J. M., & Ċastrén, E. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.003
Lin, E., Kuo, P.-H., Liu, Y.-L., Yang, A., & Tsai, S.-J. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_30_19
Metadata
- Authors
- Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S.
- Affiliations
- Kanazawa University (JP)
- Yale University (US)
- Sumitomo Dainippon Pharma (Japan) (JP)
- Corresponding author
- Duman, Ronald S.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 86
- Issue
- 2
- Pages
- 143-152
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC6597338
- OpenAlex
- W2907856418
- Cited by
- 116
- References
- 66
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 12 · 2023: 22 · 2022: 17 · 2021: 20 · 2020: 14 · 2019: 10
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH045481, MH093897)
- State of Connecticut
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, vascular endothelial growth factor, antidepressant effects, ketamine, medial prefrontal cortex, VEGF neutralizing antibody, neurotrophic signaling
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Cerebral Cortex, Male, Mice, Inbred C57BL, Microinjections, Neurons, Gene Deletion, Prefrontal Cortex, Nootropic Agents, Antibodies, Blocking, Brain-Derived Neurotrophic Factor, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Mice, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review